Skip to main content
TipRanks
Go Ultimate75% OFF

Regional Health Properties (RHEP) AI Stock Analysis

289 Followers
RHEP

Regional Health Properties

(Other OTC:RHEP)

Select Model
Rating:47Neutral
Price Target:$0.90â–¼(-4.95% Downside)
Action:reiterated
Date:11/13/26

Weak financial fundamentals, particularly negative equity and poor cash-flow quality, are the primary risks. Bearish technical positioning further weighs on the score, while the very low P/E ratio provides the main offset.

Positive Factors
Healthcare Real Estate FocusA focused healthcare real estate model gives Regional Health Properties a defined operating niche built around owning and leasing facilities used by healthcare providers. This asset-based platform can support recurring property income and keeps the business aligned with an established healthcare infrastructure market.
Negative Factors
Negative Equity and LeverageNegative equity and an unstable historical leverage profile materially weaken financial flexibility. This structure can make refinancing more difficult, limit the company’s ability to fund property investment internally, and increase sensitivity to asset values, liabilities, and restructuring requirements over the next several quarters.

Regional Health Properties (RHEP) vs. SPDR S&P 500 ETF (SPY)

-40%-30%-20%-10%0%10%20%RHEP-32.14%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$3.60M
Dividend Yield
―
Average Volume (3M)
2,511
Price to Earnings (P/E)
1.1
Beta (1Y)
1.21
Revenue Growth
139.56%
EPS Growth
96.77%
Country
US
Employees
731
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Regional Health Properties Business Overview & Revenue Model

Company Description

Regional Health Properties, Inc. (RHEP) functions as an independently managed real estate investment company, operating through its subsidiaries. Its core investment strategy centers on properties specifically developed for long-term care and senior...

Regional Health Properties Financial Statement Overview

Summary

Revenue growth and lower debt are offset by negative equity, inconsistent profitability, declining margins, and negative free cash flow.

Income Statement

58Neutral

Balance Sheet

20Very Negative

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Dec 2022Dec 2021
Income Statement
Total Revenue91.39M53.16M18.34M17.16M35.92M26.69M
Gross Profit17.78M14.61M8.30M8.00M9.98M10.31M
EBITDA5.27M8.10M2.22M1.12M-1.93M4.08M
Net Income-164.00K3.37M-3.22M-3.89M-6.87M-1.18M
Balance Sheet
Total Assets67.50M68.55M60.47M62.18M68.58M105.70M
Cash, Cash Equivalents and Short-Term Investments1.65M3,013582.00K953.00K843.00K6.79M
Total Debt2.04M42.48M43.96M45.68M55.40M84.94M
Total Liabilities65.42M63.51M63.38M62.00M64.86M95.30M
Stockholders Equity-2.61M5.04M-2.92M185.00K3.72M10.40M
Cash Flow
Free Cash Flow-564.00K-3,1291.41M2.75M-3.88M4.77M
Operating Cash Flow1.23M-2,2601.94M3.71M-3.60M4.89M
Investing Cash Flow8.20M15.10M-530.00K-958.00K-281.00K-123.00K
Financing Cash Flow-8.53M-10.25M-2.13M-2.48M-2.06M-2.42M

Regional Health Properties Technical Analysis

Technical Analysis SentimentNegative
Last Price0.95

Price Trends

50DMA1.01Negative
100DMA1.04Negative
200DMA1.16Negative

Market Momentum

MACD-0.02Positive
RSI43.99Neutral
STOCH60.42Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RHEP, the sentiment is Negative. The current price of 0.95 is below the 20-day moving average (MA) of 1.00, below the 50-day MA of 1.01, and below the 200-day MA of 1.16, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 43.99 is Neutral, neither overbought nor oversold. The STOCH value of 60.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RHEP.

Regional Health Properties Risk Analysis

Regional Health Properties disclosed 39 risk factors in its most recent earnings report. Regional Health Properties reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The market price of our securities may be volatile.Q4, 2025
2.The rights of holders of our preferred stock are senior to those of our common shareholders, and the rights among our series of preferred stock are not identical.Q4, 2025
3.Shareholders may experience dilution or reduced voting influence as a result of past or future merger and financing transactions.Q4, 2025

Regional Health Properties Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

RHEP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
NHCNHC68Neutral$3.30B28.2110.41%1.26%5.71%12.44%
PNTGPNTG61Neutral$1.26B34.6810.15%―38.67%33.07%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
BKDBKD47Neutral$2.14B-57.7188.80%―-8.42%87.98%
RHEPRHEP47Neutral$3.60M1.10-7.18%―139.56%96.77%
SNDASNDA45Neutral$1.63B-6.17-19.40%―69.98%-86.89%
CYHCYH44Neutral$311.67M8.30-2.51%―-7.84%-88.93%

* Healthcare Sector Average

Performance Comparison

0%50%RHEPBKDSNDACYHNHCPNTGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
RHEP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
RHEPRegional Health Properties, Inc.0.95-0.45-32.14%
BKDBrookdale Senior Living Inc.9.17-1.32-12.58%
SNDASonida Senior Living, Inc.33.000.993.09%
CYHCommunity Health Systems2.24-0.77-25.58%
NHCNational Healthcare207.9383.9167.66%
PNTGPennant Group Inc36.0710.6742.01%

Regional Health Properties Corporate Events

Executive/Board ChangesShareholder Meetings

Regional Health Properties Stockholders Elect Directors, Ratify Auditor

Neutral
Nov 12, 2026

At its 2026 Annual Meeting on November 10, 2026, the company’s common stockholders elected Brent Morrison, Kenneth W. Taylor and F. Scott Kellman to the board, while Series B preferred stockholders elected Steven L. Martin and Series D preferred stoc...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 13, 2026